Genome-wide mapping of cystitis due to Streptococcus agalactiae and Escherichia coli in mice identifies a unique bladder transcriptome that signifies pathogen-specific antimicrobial defense against urinary tract infection

Infection and Immunity

Volumn 80, Issue 9, 2012, Pages 3145-3160

  Tan, Chee K ^a   Carey, Alison J ^a   Cui, Xiangqin ^b,c   Webb, Richard I ^f   Ipe, Deepak ^a   Crowley, Michael ^e   Cripps, Allan W ^a   Benjamin, William H ^f   Ulett, Kimberly B ^c,g   Schembri, Mark A ^f   Ulett, Glen C ^a,d  

^a GRIFFITH UNIVERSITY   (Australia)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; RNA; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BACTERIAL LOAD; BACTERIUM CULTURE; BIOSYNTHESIS; BLADDER; CYSTITIS; ESCHERICHIA COLI; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE MAPPING; GROUP B STREPTOCOCCAL INFECTION; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOCOCCUS AGALACTIAE; URINARY TRACT INFECTION;

EID: 84866396945     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00023-12     Document Type: Article

References (97)

1. Anderson BL, Simhan HN, Simons KM, Wiesenfeld HC. 2007. Untreated asymptomatic group B streptococcal bacteriuria early in pregnancy and chorioamnionitis at delivery. Am. J. Obstet. Gynecol. 196: 524.e1-524.e5.
2. Ashburner M, et al. 2000. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25:25-29.
3. Baker CJ. 2000. Group B streptococcal infections, p 222-237. In Stevens DL, Kaplan EL (ed), Streptococcal infections. Clinical aspects, microbiology, and molecular pathogenesis. Oxford University Press, New York, NY.
4. Barry WT, Nobel AB, Wright FA. 2005. Significance analysis of functional categories in gene expression studies: a structured permutation approach. Bioinformatics 21:1943-1949. doi:10.1093/bioinformatics/bti260.
5. Bender L, et al. 2008. Early and late markers for the detection of earlyonset neonatal sepsis. Dan. Med. Bull. 55:219-223.
6. Berende A, Oosting M, Kullberg BJ, Netea MG, Joosten LA. 2010. Activation of innate host defense mechanisms by Borrelia. Eur. Cytokine Netw. 21:7-18.
7. Billips BK, et al. 2007. Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli. Infect. Immun. 75:5353-5360.
8. Candela JV, et al. 1998. Evaluation of urinary IL-1alpha and IL-1beta in gravid females and patients with bacterial cystitis and microscopic hematuria. Urol. Res. 26:175-180.
9. Cui X. 2010. Experimental designs on high-throughput biological experiments, p 201-217. In Lee JK (ed), Statistical bioinformatics: for biomedical and life science researchers. Wiley-Blackwell, Hoboken, NJ.
10. Cui X, Hwang JT, Qiu J, Blades NJ, Churchill GA. 2005. Improved statistical tests for differential gene expression by shrinking variance components estimates. Biostatistics 6:59-75. doi:10.1093/biostatistics/kxh018.
11. Dinarello CA. 2011. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117:3720-3732. doi:10.1182/blood-2010-07-273417.
12. Draper DW, Bethea HN, He YW. 2006. Toll-like receptor 2-dependent and -independent activation of macrophages by group B streptococci. Immunol. Lett. 102:202-214.
13. Duell BL, et al. 2012. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection. J. Immunol. 188:781-792. doi:10.4049/jimmunol. 1101231.
14. Duell BL, Cripps AW, Schembri MA, Ulett GC. 2011. Epithelial cell coculture models for studying infectious diseases: benefits and limitations. J. Biomed. Biotechnol. 2011:852419.
15. Edwards MS, Baker CJ. 2005. Group B streptococcal infections in elderly adults. Clin. Infect. Dis. 41:839-847.
16. Engel D, et al. 2006. Tumor necrosis factor alpha-and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance. Infect. Immun. 74:6100-6107.
17. Eskra L, Mathison A, Splitter G. 2003. Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus. Infect. Immun. 71:1125-1133.
18. Evans SE, et al. 2010. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am. J. Respir. Cell Mol. Biol. 42:40-50.
19. Falagas ME, Rosmarakis ES, Avramopoulos I, Vakalis N. 2006. Streptococcus agalactiae infections in non-pregnant adults: single center experience of a growing clinical problem. Med. Sci. Monit. 12:CR447-CR451.
20. Fida NM, Al-Mughales JA, Fadelallah MF. 2006. Serum concentrations of interleukin-1 alpha, interleukin-6 and tumor necrosis factor-alpha in neonatal sepsis and meningitis. Saudi Med. J. 27:1508-1514.
21. Fischer H, et al. 2010. Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. PLoS Pathog. 6:e1001109. doi:10.1371/journal.ppat.1001109.
22. Fischer H, Yamamoto M, Akira S, Beutler B, Svanborg C. 2006. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur. J. Immunol. 36: 267-277.
23. Fong CH, et al. 2008. An antiinflammatory role for IKKbeta through the inhibition of "classical" macrophage activation. J. Exp. Med. 205:1269-1276.
24. Foxman, B. 2002. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 113(Suppl. 1A):5S-13S.
25. Hang L, et al. 1999. Macrophage inflammatory protein-2 is required for neutrophil passage across the epithelial barrier of the infected urinary tract. J. Immunol. 162:3037-3044.
26. Hedlund M, Svensson M, Nilsson A, Duan RD, Svanborg C. 1996. Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J. Exp. Med. 183:1037-1044.
27. Henneke P, et al. 2001. Novel engagement of CD14 and multiple toll-like receptors by group B streptococci. J. Immunol. 167:7069-7076.
28. Ingersoll MA, Kline KA, Nielsen HV, Hultgren SJ. 2008. G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity. Cell Microbiol. 10:2568-2578. doi:10.1111/j.1462-5822.2008.01230.x.
29. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M. 2004. The KEGG resource for deciphering the genome. Nucleic Acids Res. 32:D277-D280. doi:10.1093/nar/gkh063.
30. Kau AL, et al. 2005. Enterococcus faecalis tropism for the kidneys in the urinary tract of C57BL/6J mice. Infect. Immun. 73:2461-2468.
31. Kenzel S, et al. 2009. Role of p38 and early growth response factor 1 in the macrophage response to group B streptococcus. Infect. Immun. 77:2474-2481.
32. Khalil A, et al. 1997. Cytokine gene expression during experimental Escherichia coli pyelonephritis in mice. J. Urol. 158:1576-1580. doi: 10.1016/S0022-5347(01)64282-4.
33. Klemm P, Roos V, Ulett GC, Svanborg C, Schembri MA. 2006. Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen. Infect. Immun. 74:781-785.
34. Klemm P, Schembri MA. 2000. Bacterial adhesins: function and structure. Int. J. Med. Microbiol. 290:27-35.
35. Kline KA, Schwartz DJ, Lewis WG, Hultgren SJ, Lewis AL. 2011. Immune activation and suppression by group B streptococcus in a murine model of urinary tract infection. Infect. Immun. 79:3588-3595.
36. Lee EY, Lee ZH, Song YW. 2009. CXCL10 and autoimmune diseases. Autoimmun. Rev. 8:379-383.
37. Liu PT, et al. 2009. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 4:e5810. doi:10.1371/journal.pone.0005810.
38. Lloyd AL, Smith SN, Eaton KA, Mobley HL. 2009. Uropathogenic Escherichia coli suppresses the host inflammatory response via pathogenicity island genes sisA and sisB. Infect. Immun. 77:5322-5333.
39. Lynn DJ, et al. 2010. Curating the innate immunity interactome. BMC Syst. Biol. 4:117.
40. Lynn DJ, et al. 2008. InnateDB: facilitating systems-level analyses of the mammalian innate immune response. Mol. Syst. Biol. 4:218.
41. Mabbett AN, et al. 2009. Virulence properties of asymptomatic bacteriuria Escherichia coli. Int. J. Med. Microbiol. 299:53-63.
42. Mancuso G, et al. 2004. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease. J. Immunol. 172:6324-6329.
43. Mobley HL, et al. 1990. Pyelonephritogenic Escherichia coli and killing of cultured human renal proximal tubular epithelial cells: role of hemolysin in some strains. Infect. Immun. 58:1281-1289.
44. Moller M, Thomsen AC, Borch K, Dinesen K, Zdravkovic M. 1984. Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet ii:69-70.
45. Mühl H, Bachmann M, Pfeilschifter J. 2011. Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity. Cell Microbiol. 13:340-348. doi:10.1111/j.1462-5822.2010.01559.x.
46. Muller AE, Oostvogel PM, Steegers EA, Dorr PJ. 2006. Morbidity related to maternal group B streptococcal infections. Acta Obstet. Gynecol. Scand. 85:1027-1037.
47. Oelschlaeger TA, Dobrindt U, Hacker J. 2002. Virulence factors of uropathogens. Curr. Opin. Urol. 12:33-38.
48. Ogata H, et al. 1999. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 27:29-34. doi:10.1093/nar/27.1.29.
49. Okazaki K, et al. 2008. Temporal alterations in concentrations of sera cytokines/chemokines in sepsis due to group B streptococcus infection in a neonate. Jpn. J. Infect. Dis. 61:382-385.
50. Olszyna DP, et al. 2001. CXC chemokine receptor 2 contributes to host defense in murine urinary tract infection. J. Infect. Dis. 184:301-307.
51. Oregioni O, et al. 2005. Urinary interleukin-8 is elevated in urinary tract infections independently of the causative germs. Cytokine 31:415-418. doi:10.1016/j.cyto.2005.06.009.
52. Otto G, Braconier J, Andreasson A, Svanborg C. 1999. Interleukin-6 and disease severity in patients with bacteremic and nonbacteremic febrile urinary tract infection. J. Infect. Dis. 179:172-179.
53. Otto G, Burdick M, Strieter R, Godaly G. 2005. Chemokine response to febrile urinary tract infection. Kidney Int. 68:62-70. doi:10.1111/j.1523-1755.2005.00381.x.
54. Persson K, Bjerre B, Elfstrom L, Polberger S, Forsgren A. 1986. Group B streptococci at delivery: high count in urine increases risk for neonatal colonization. Scand. J. Infect. Dis. 18:525-531.
55. Persson K, et al. 1985. Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. Scand. J. Infect. Dis. 17:195-199.
56. Pfaffl MW. 2001. A new mathematical model for relative quantification in real time RT-PCR. Nucleic Acids Res. 29:e45. doi:10.1093/nar/29.9.e45.
57. Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30:e36. doi: 10.1093/nar/30.9.e36.
58. Puliti M, Bistoni F, Tissi L. 2010. Lack of B7-1 and B7-2 costimulatory molecules modulates the severity of group B Streptococcus-induced arthritis. Microbes Infect. 12:302-308. doi:10.1016/j.micinf.2010.01.006.
59. Puliti M, Uematsu S, Akira S, Bistoni F, Tissi L. 2009. Toll-like receptor 2 deficiency is associated with enhanced severity of group B streptococcal disease. Infect. Immun. 77:1524-1531.
60. Ragnarsdóttir B, et al. 2008. TLR-and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur. J. Clin. Invest. 38(Suppl. 2):12-20.
61. Reed LJ, Muench HA. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. (Lond.) 27:493-497.
62. Reyes L, Reinhard M, Brown MB. 2009. Different inflammatory responses are associated with Ureaplasma parvum-induced UTI and urolith formation. BMC Infect. Dis. 9:9.
63. Ronald, A. 2002. The etiology of urinary tract infection: traditional and emerging pathogens. Am. J. Med. 113(Suppl. 1A):14S-19S.
64. Roos V, Ulett GC, Schembri MA, Klemm P. 2006. The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect. Immun. 74:615-624.
65. Rouschop KM, et al. 2006. Urothelial CD44 facilitates Escherichia coli infection of the murine urinary tract. J. Immunol. 177:7225-7232.
66. Säemann MD, Weichhart T, Horl WH, Zlabinger GJ. 2005. Tamm-Horsfall protein: a multilayered defence molecule against urinary tract infection. Eur. J. Clin. Invest. 35:227-235.
67. Säemann MD, et al. 2005. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J. Clin. Invest. 115:468-475. doi:10.1172/JCI22720.
68. Sheu JN, et al. 2006. Serum and urine levels of interleukin-6 and interleukin-8 in children with acute pyelonephritis. Cytokine 36:276-282. doi: 10.1016/j.cyto.2007.02.006.
69. Sivick KE, Mobley HL. 2010. Waging war against uropathogenic Escherichia coli: winning back the urinary tract. Infect. Immun. 78:568-585.
70. Sivick KE, Schaller MA, Smith SN, Mobley HL. 2010. The innate immune response to uropathogenic Escherichia coli involves IL-17A in a murine model of urinary tract infection. J. Immunol. 184:2065-2075. doi: 10.4049/jimmunol.0902386.
71. Smith PD, et al. 2011. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol. 4:31-42. doi:10.1038/mi.2010.66.
72. Song J, Bishop BL, Li G, Duncan MJ, Abraham SN. 2007. TLR4-initiated and cAMP-mediated abrogation of bacterial invasion of the bladder. Cell Host Microbe 1:287-298. doi:10.1016/j.chom.2007.05.007.
73. Song J, et al. 2009. TLR4-mediated expulsion of bacteria from infected bladder epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 106:14966-14971.
74. Svanborg C, et al. 2001. The 'innate' host response protects and damages the infected urinary tract. Ann. Med. 33:563-570.
75. Svanborg C, et al. 2006. Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr. Opin. Microbiol. 9:33-39.
76. Tabibian JH, et al. 2008. Uropathogens and host characteristics. J. Clin. Microbiol. 46:3980-3986.
77. Tan CK, et al. 2011. Abstr. 111th Annu. Gen. Meet. Am. Soc. Microbiol., 21 to 24 May 2011, New Orleans, LA, abstr 11-GM-A-2691.
78. Trigo G, et al. 2009. Leukocyte populations and cytokine expression in the mammary gland in a mouse model of Streptococcus agalactiae mastitis. J. Med. Microbiol. 58:951-958.
79. Ulett GC, Adderson EE. 2005. Nitric oxide is a key determinant of group B streptococcus-induced murine macrophage apoptosis. J. Infect. Dis. 191:1761-1770.
80. Ulett GC, Adderson EE. 2006. Regulation of apoptosis by Gram-positive bacteria: mechanistic diversity and consequences for immunity. Curr. Immunol. Rev. 2:119-141.
81. Ulett GC, Bohnsack JF, Armstrong J, Adderson EE. 2003. Betahemolysin-independent induction of apoptosis of macrophages infected with serotype III group B streptococcus. J. Infect. Dis. 188:1049-1053.
82. Ulett GC, Maclean KH, Nekkalapu S, Cleveland JL, Adderson EE. 2005. Mechanisms of group B streptococcal-induced apoptosis of murine macrophages. J. Immunol. 175:2555-2562.
83. Ulett GC, et al. 2007. Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long term persistence in the urinary tract. Infect. Immun. 75:3233-3244.
84. Ulett GC, et al. 2010. Group B Streptococcus (GBS) urinary tract infection involves binding of GBS to bladder uroepithelium and potent but GBS-specific induction of interleukin 1alpha. J. Infect. Dis. 201:866-870.
85. Ulett KB, et al. 2009. Diversity of group B streptococcus serotypes causing urinary tract infection in adults. J. Clin. Microbiol. 47:2055-2060.
86. Valle J, et al. 2008. UpaG, a new member of the trimeric autotransporter family of adhesins in uropathogenic Escherichia coli. J. Bacteriol. 190: 4147-4161. doi:10.1128/JB.00122-08.
87. Von Hunolstein C, et al. 1997. Soluble antigens from group B streptococci induce cytokine production in human blood cultures. Infect. Immun. 65:4017-4021.
88. von Hunolstein C, Totolian A, Alfarone G, Teti G, Orefici G. 1997. Cytokine production in an ex vivo whole blood model following induction by group B streptococcal polysaccharides and lipoteichoic acid. Adv. Exp. Med. Biol. 418:893-896.
89. Watanabe T, et al. 2010. NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway. J. Clin. Invest. 120:1645-1662. doi:10.1172/JCI39481.
90. Watts RE, et al. 2012. Contribution of siderophore systems to growth and urinary tract colonization of asymptomatic bacteriuria Escherichia coli. Infect. Immun. 80:333-344.
91. Wood EG, Dillon HC, Jr. 1981. A prospective study of group B streptococcal bacteriuria in pregnancy. Am. J. Obstet. Gynecol. 140:515-520.
92. Wright KJ, Hultgren SJ. 2006. Sticky fibers and uropathogenesis: bacterial adhesins in the urinary tract. Future Microbiol. 1:75-87. doi:10.2217/17460913.1.1.75.
93. Yadav M, et al. 2010. Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog. 6:e1001120. doi:10.1371/journal.ppat.1001120.
94. Yin X, et al. 2010. Enhancement of the innate immune response of bladder epithelial cells by Astragalus polysaccharides through upregulation of TLR4 expression. Biochem. Biophys. Res. Commun. 397:232-238.
95. Zaheer RS, Proud D. 2010. Human rhinovirus-induced epithelial production of CXCL10 is dependent upon IFN regulatory factor-1. Am. J. Respir. Cell Mol. Biol. 43:413-421.
96. Zasloff M. 2007. Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J. Am. Soc. Nephrol. 18:2810-2816.
97. Zhang X, et al. 2004. Gene expression in mature neutrophils: early responses to inflammatory stimuli. J. Leukoc. Biol. 75:358-372.